Scholar Rock Holding Net Profit Margin 2017-2022 | SRRK
Scholar Rock Holding net profit margin from 2017 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Scholar Rock Holding Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2022-03-31 |
$0.05B |
$-0.11B |
-240.43% |
| 2021-12-31 |
$0.02B |
$-0.13B |
-700.00% |
| 2021-09-30 |
$0.02B |
$-0.12B |
-688.89% |
| 2021-06-30 |
$0.02B |
$-0.11B |
-687.50% |
| 2021-03-31 |
$0.02B |
$-0.10B |
-653.33% |
| 2020-12-31 |
$0.02B |
$-0.09B |
-580.00% |
| 2020-09-30 |
$0.02B |
$-0.07B |
-360.00% |
| 2020-06-30 |
$0.02B |
$-0.06B |
-290.91% |
| 2020-03-31 |
$0.02B |
$-0.06B |
-252.17% |
| 2019-12-31 |
$0.02B |
$-0.05B |
-247.62% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.174B |
$0.019B |
|
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
|
